Carvacrol attenuated haloperidol-induced Parkinson’s disease via TNF/NFκβ-NLRP3-mediated pyroptosis
Abstract Background Parkinson’s disease is a debilitating and the second most common neurodegenerative disorder with a high prevalence. Parkinson’s disease has a multifaceted etiology characterized by an altered redox state and an excessive inflammatory response. In this study, we investigated the p...
Saved in:
| Main Authors: | Faisal Albaqami, Khawaja Waqas Ahmad, Fawad Ali Shah |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-02-01
|
| Series: | Laboratory Animal Research |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s42826-025-00237-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Haloperidol for the treatment of delirium in ICU patients: a systematic review and meta‑analysis
by: Yue Zhao, et al.
Published: (2025-03-01) -
Dystonic reaction to haloperidol causing severe tongue swelling requiring cricothyroidotomy
by: Carmen Estrada Huerta, et al.
Published: (2025-06-01) -
Haloperidol-induced painless legs and moving toe syndrome in a schizophrenia patient: a case report
by: Mugundan U Maheshwari, et al.
Published: (2024-12-01) -
Haloperidol drug repurposing unveils ferroptosis involvement in breast cancer cells
by: Valeria Consoli, et al.
Published: (2025-07-01) -
Suppression of Epidermal Growth Factor Receptor by Erlotinib Attenuates Carvacrol-induced Skin Inflammation
by: Yujing Wang, et al.
Published: (2024-12-01)